Novo Nordisk Becomes Europe's Most Valuable Company as Wegovy Launches in UK
Novo Nordisk pulled ahead of LVMH to become Europe’s most valuable company by market capitalization as it launches its popular weight-loss drug, Wegovy, in the U.K.
( 1
min )